Chronic Obstructive Airways Disease Exacerbated study: Digital Inhaler Attachment
Official title Digital Inhaler Use in Obstructive Lung Disease Care
ClinicalTrials.gov ID: NCT07214337
What this study is testing
- What it's testing
- This is a study to look at the role digital inhaler technology on patients with obstructive lung disease in preventing admissions and exacerbation, as well as improving symptom control.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Any sex
- Over the age of 18 years.
- Physician-diagnosed obstructive lung disease
- Speak, read, and understand English.
- The current study is a feasibility pilot. Based on the results of the study, future studies will include non-English speakers as well.
You likely can't join if
- Physically disabled such that they are incapable of using digital devices or metered dose inhalers.
- Suffer from any visual, hearing or cognitive impairment that cannot be corrected enough to operate the devices properly.
- Suffering from serious uncontrolled medical conditions that may interfere with study conduct.
- Inability or unwillingness of the participant to give written informed consent.
- Pregnant women (due to complicated physiology)
- The current study is a feasibility pilot. Based on the results of the study, future studies will likely include pregnant patients as well.
See the full eligibility criteria
- Any sex
- Over the age of 18 years.
- Physician-diagnosed obstructive lung disease
- Speak, read, and understand English.
- The current study is a feasibility pilot. Based on the results of the study, future studies will include non-English speakers as well.
- Able to understand study requirements and comply with study procedures.
- Ability to operate a smartphone or tablet (for questionnaire and symptoms input).
- Patients who use either a DPI or an MDI device as controller medications. Medications will not be changed by the study team.
- Physically disabled such that they are incapable of using digital devices or metered dose inhalers.
- Suffer from any visual, hearing or cognitive impairment that cannot be corrected enough to operate the devices properly.
- Suffering from serious uncontrolled medical conditions that may interfere with study conduct.
- Inability or unwillingness of the participant to give written informed consent.
- Pregnant women (due to complicated physiology)
- The current study is a feasibility pilot. Based on the results of the study, future studies will likely include pregnant patients as well.
- Prisoners
The study team makes the final eligibility decision.
Where it is enrolling
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Los Angeles, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.